Pricing Log in Create free account

Lakewood-Amedex Biotherapeutics Inc. (LABT) vs Matinas Biopharma Holdings, Inc. (MTNB)

Lakewood-Amedex Biotherapeutics Inc. and Matinas Biopharma Holdings, Inc. are both Biotechnology companies. Lakewood-Amedex Biotherapeutics Inc. is the larger, with a market value of $1.3M against $1.1M — 1.1× the size. Across the 11 metrics below, Lakewood-Amedex Biotherapeutics Inc. leads on 7 and Matinas Biopharma Holdings, Inc. on 4.

Valuation

Metric LABT MTNB Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.12 9.40
P/B 0.12 0.30 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.71 0.04 0.66
EV/Sales n/m (0.06) 9.02
Earnings yield (2,135.14%) (1,403.30%) (32.88%)
Free cash flow yield (934.12%) (1,142.24%) (23.13%)

Profitability

Metric LABT MTNB Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (154.28%) (51.96%)
Return on assets (302.50%) (98.53%) (46.06%)
Return on invested capital 0.00% (419.27%) 0.00%

Growth

Metric LABT MTNB Biotechnology median
Revenue growth (TTM) — 2,135.91% 6.76%
EPS growth (last fiscal year) 15.32% 59.84% 29.88%
Revenue growth, 5-year CAGR — 55.69% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric LABT MTNB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.70 0.85 4.97
Net debt to EBITDA 0.06 0.62 1.01

Dividend

Metric LABT MTNB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LABT MTNB Biotechnology median
Market cap 1.27m 1.14m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack